Synapse - Shakeel Modak

Search Within

Shakeel Modak

Results (49)

Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA

Meeting Abstract

Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
Pediatric Blood and Cancer (2016)

Fulltext@MSK | Save

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
Oncotarget (2016)

Fulltext@MSK | Save

Long-term pulmonary outcomes in survivors of high-risk neuroblastoma

Meeting Abstract

Stone, A.; Friedman, D. N.; Worgall, S.; Kushner, B.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Christos, P.; Cheung, N. K.; Sklar, C. A.
American Journal of Respiratory and Critical Care Medicine (2015)

Fulltext@MSK | Save

Predisposing factors for short stature in long-term survivors of high-risk neuroblastoma

Meeting Abstract

Yang, J. C.; Friedman, D. N.; Woo, K. M.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; Roberts, S. S.; Basu, E. M.; Wolden, S. L.
International Journal of Radiation Oncology, Biology, Physics (2015)

Fulltext@MSK | Save

Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: A prospective phase II study

Journal Article

Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Kramer, K.; Modak, S.; Yataghene, K.; Cheung, N. K. V.
OncoImmunology (2015)

Fulltext@MSK | Save

Osteochondroma in long-term survivors of high-risk neuroblastoma

Journal Article

Kushner, B. H.; Roberts, S. S.; Friedman, D. N.; Kuk, D.; Ostrovnaya, I.; Modak, S.; Kramer, K.; Basu, E. M.; Cheung, N. K. V.
Cancer (2015)

Fulltext@MSK | Save

Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kramer, K.; Modak, S.; Kuk, D.; Pandit-Taskar, N.; Chamberlain, E.; Ostrovnaya, I.; Kushner, B. H.
International Journal of Cancer (2014)

Fulltext@MSK | Save

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission

Journal Article

Kushner, B. H.; Cheung, I. Y.; Modak, S.; Kramer, K.; Ragupathi, G.; Cheung, N. K. V.
Clinical Cancer Research (2014)

Fulltext@MSK | Save

Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma

Journal Article

Modak, S.; Kushner, B. H.; Kramer, K.; Vickers, A.; Cheung, I. Y.; Cheung, N. K. V.
OncoImmunology (2013)

Fulltext@MSK | Save

Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission

Journal Article

Cheung, N. K. V.; Cheung, I. Y.; Kushner, B. H.; Ostrovnaya, I.; Chamberlain, E.; Kramer, K.; Modak, S.
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save